series-c-plus
Stage
2002
Founded
1
Investors
About
Hemarina is a French biotech company developing therapeutic products based on the extracellular hemoglobin of the marine annelid Arenicola marina. These products aim to improve tissue and organ oxygenation for applications in transplantation, wound healing, and other medical fields.
Explore Hemarina's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.